SANION Saniona AB (publ)

1.107USD11.23 SEK · STO+0.36%Mkt Cap: 152.85M USDP/E: 8.71

Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…

Key Statistics

Company
Market Cap152.85M USD
Enterprise Value104.90M USD
Revenue (TTM)41.87M USD
Gross Profit42.30M USD
Net Income (TTM)28.07M USD
Revenue/Share0.31 USD
Last Price1.107 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0005794617
Valuation
P/E (Trailing)8.71
P/E (Forward)—
PEG—
EV/EBITDA5.22
EV/Revenue2.51
P/S3.65
P/B2.83
EPS (TTM)0.13 USD
EPS (Forward)—
52W Range
0.840614% of range2.791
52W High2.791 USD
52W Low0.8406 USD
Profitability
Gross Margin98.75%
Oper. Margin47.14%
EBITDA Margin47.96%
Profit Margin65.53%
ROE44.82%
ROA41.88%
ROIC470.35%
ROCE43.25%
Growth
Revenue Growth-51.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF27.00M USD
CapEx (TTM)7.25M USD
FCF Margin28.12%
FCF Yield7.70%
Net Debt-47.96M USD
Net Debt/EBITDA-2.39
Net Debt/FCF-4.07
Balance Sheet
Debt/Equity0.00
Current Ratio9.65
Quick Ratio9.30
Book Value/Sh0.39 USD
Cash/Share0.35 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.874 USD
Upside (mean)+69.2%
Target Range1.874 USD – 1.874 USD
# Analysts1
Ownership
Shares Out.138.03M
Float121.20M
Insiders7.64%
Institutions24.17%
Technical
SMA 501.030 (+7.5%)
SMA 2001.343 (-17.5%)
Beta1.18
S&P 52W Chg8.68%
Avg Vol (30d)346.95K
Avg Vol (10d)346.78K
Technical Indicators
RSI (14)50.7
MACD0.2781
MACD Signal0.3359
MACD Hist.-0.0578
BB Upper1.221 USD
BB Middle1.122 USD
BB Lower1.023 USD
BB Width17.61%
ATR (14)0.0637 USD
Vol Ratio (20d)0.82x

About Saniona (STO: SANION)

›

Saniona (STO: SANION) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 44 employees.

The shares were at 11.23 SEK on 20 November 2026, down 24.7% over 52 weeks. Its 52-week range is 8.525 SEK to 28.30 SEK: the price is 60.3% below the high and 31.7% above the low.

At a market capitalisation of 1.55B SEK, it trades at 8.7 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.1, a discount of 74% for SANION.

Saniona reports return on equity of 44.8%, an operating margin of 47.1% and revenue down 51.0% year over year.

It holds more cash than debt, a net cash position of 486.31M SEK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 19.00 SEK is 69.2% above the current price.